michigan semaglutide digestive blockage class action gastrointestinal obstruction Subocclusive ileus following off-label high-dose semaglutide use in: Endocrinology, Diabetes & Metabolism Case Reports Volume 2025 Issue 4 (2025) FDA warns Ozempic and Wegovy
Description
GLP-1 Reduces appetite, increases fullness, improves glucose dependent insulin response and delays gastric emptying
muciniphila was first discovered by Derrien et al
Fortunately, acne can be treated and even prevented in some cases
For people taking semaglutide as part of a diabetes management program, this risk is compounded
Some people on GLP-1 type medications report feeling intoxicated faster, likely because slowed stomach emptying changes alcohol absorption
